- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.10 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x PO4- PO4- A- A- A- A- PO4: RNA (5'-R(P*(PO4)P*(PO4)P*AP*AP*AP*AP*(PO4))-2')(Non-covalent)
- 2 x ACP: PHOSPHOMETHYLPHOSPHONIC ACID ADENYLATE ESTER(Non-covalent)
ACP.3: 20 residues within 4Å:- Chain A: I.351, A.352, T.354, S.355, I.359, A.370, K.372, R.380, V.414, T.415, L.416, C.417, T.420, Q.469, N.470, L.472, D.483, D.485
- Ligands: MG.4, MG.5
12 PLIP interactions:12 interactions with chain A- Hydrogen bonds: A:S.355, A:S.355, A:K.372, A:R.380, A:R.380, A:T.415, A:C.417, A:D.483
- Water bridges: A:D.465, A:N.470, A:D.483
- Salt bridges: A:K.372
ACP.6: 19 residues within 4Å:- Chain B: I.351, A.352, T.354, S.355, I.359, A.370, K.372, R.380, V.414, T.415, C.417, T.420, Q.469, N.470, L.472, D.483, D.485
- Ligands: MG.7, MG.8
16 PLIP interactions:16 interactions with chain B- Hydrogen bonds: B:S.355, B:S.355, B:K.372, B:R.380, B:R.380, B:T.415, B:C.417, B:D.483
- Water bridges: B:D.465, B:Q.467, B:Q.467, B:Q.469, B:N.470, B:D.483, B:D.483
- Salt bridges: B:K.372
- 4 x MG: MAGNESIUM ION(Non-covalent)
MG.4: 4 residues within 4Å:- Chain A: N.470, D.483
- Ligands: ACP.3, MG.5
3 PLIP interactions:1 interactions with chain A, 2 Ligand-Water interactions- Metal complexes: A:D.483, H2O.1, H2O.1
MG.5: 6 residues within 4Å:- Chain A: K.372, D.465, D.483, D.485
- Ligands: ACP.3, MG.4
5 PLIP interactions:3 interactions with chain A, 2 Ligand-Water interactions- Metal complexes: A:D.483, A:D.483, A:D.485, H2O.1, H2O.10
MG.7: 4 residues within 4Å:- Chain B: N.470, D.483
- Ligands: ACP.6, MG.8
3 PLIP interactions:1 interactions with chain B, 2 Ligand-Water interactions- Metal complexes: B:D.483, H2O.19, H2O.33
MG.8: 6 residues within 4Å:- Chain B: K.372, D.465, D.483, D.485
- Ligands: ACP.6, MG.7
5 PLIP interactions:3 interactions with chain B, 2 Ligand-Water interactions- Metal complexes: B:D.483, B:D.483, B:D.485, H2O.33, H2O.33
- 1 x PUP: (2R,3S,4R,5R)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-4-hydroxy-2-({[(S)-hydroxy{[(2R,3S,4S)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl]oxy}phosphoryl]oxy}methyl)tetrahydrofuran-3-yl dihydrogen phosphate(Non-covalent)
PUP.9: 10 residues within 4Å:- Chain A: R.647
- Chain B: K.586, T.587, M.624, F.627, Y.628, R.631, R.647, N.648, N.652
12 PLIP interactions:1 interactions with chain A, 11 interactions with chain B- Hydrogen bonds: A:R.647, B:Y.628, B:Y.628, B:R.631, B:R.647, B:N.652, B:N.652
- Hydrophobic interactions: B:F.627, B:N.648
- Water bridges: B:R.647, B:N.648
- pi-Stacking: B:F.627
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Han, Y. et al., Structure of human RNase L reveals the basis for regulated RNA decay in the IFN response. Science (2014)
- Release Date
- 2014-03-12
- Peptides
- PROTEIN (RNase L): AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
BB
D
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.10 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x PO4- PO4- A- A- A- A- PO4: RNA (5'-R(P*(PO4)P*(PO4)P*AP*AP*AP*AP*(PO4))-2')(Non-covalent)
- 2 x ACP: PHOSPHOMETHYLPHOSPHONIC ACID ADENYLATE ESTER(Non-covalent)
- 4 x MG: MAGNESIUM ION(Non-covalent)
- 1 x PUP: (2R,3S,4R,5R)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-4-hydroxy-2-({[(S)-hydroxy{[(2R,3S,4S)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl]oxy}phosphoryl]oxy}methyl)tetrahydrofuran-3-yl dihydrogen phosphate(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Han, Y. et al., Structure of human RNase L reveals the basis for regulated RNA decay in the IFN response. Science (2014)
- Release Date
- 2014-03-12
- Peptides
- PROTEIN (RNase L): AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
BB
D